课题基金 / 基金详情

Functional Genomics of Chemical-Induced Acute Lung Injury

Functional Genomics of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
批准号:
8901168
负责人:
George Douglas Leikauf
金额:
$69.95万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-29 至 2017-04-30

项目摘要

项目成果

George Douglas Leikauf的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chemical-induced acute lung injury (CIALI) can result from numerous chemical threats that avail themselves to terrorist attacks. Therapies are needed to treat the acute effects and pathologies that are common to several chemical threat agents. Despite intensive effort, much remains to be understood regarding pathological events linking Inhalation exposures to delayed pulmonary edema, respiratory failure, and ultimately death. In past funding period we developed and validated mouse models of acute lung injury to 5 common chemicals (acrolein, ammonia, chlorine, phosgene, and sulfuric acid). Using a functional genomics approach, 40 mouse strains were used to identify candidate genes associated with survival time following exposure. We combined the results to build a protein interaction network (interactome). Within this network, a cell signaling hub (i.e. a protein with several protein-protein interactions) was uncovered that implicated v- AKT1 thymoma viral oncogene homolog 1 (AKT1). When phosphorylated, AKT1 enhances survival by inactivating components of the cell death machinery. Although undesirable in cancer, we reasoned that short-term, reversible enhancement of the cell survival AKT1 activity could be beneficial in CIALI treatment. We subsequently found that inhibition of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a phosphatase that limits AKT1 activity, enhances epithelial repair in vitro and protect against CIALI in vivo. Hypothesis: Inhibition of PTEN activity will impart resistance to CIALI by activating signaling events that promote cell survival. Approach: Using a high content screening method, lead compounds [including a PTEN inhibitor] will be administered in vitro to test reverse of lethality in target cells. Lead compounds will be tested in mouse models of lethality from CIALI with 5 chemicals. Overall Objective: To develop a therapy that improves survival during lung injury induced by multiple chemicals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
  • 批准号:
    10708438
  • 项目类别:
  • 资助金额:
    $49.93万
  • 财政年份:
    2023
  • 负责人:
    George Douglas Leikauf
  • 依托单位:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
Countermeasure Therapeutics for Acute Lung Injury
Countermeasure Therapeutics for Acute Lung Injury
国内基金
海外基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究